GLP-1 agonists, like Ozempic and Wegovy, have been heralded as miracle drugs.

They started out as diabetes drugs, but have shown benefits well beyond diabetes – including in weight loss and other metabolic conditions.

However these are new drugs, and as more and more people take them, researchers are keeping tabs on their effects.

While the risk is small, there are potential eye-related side effects. A new study has looked into macular degeneration in particular.

Guest/s

• Dr Marko Popovic, ophthalmologist and retina specialist at the University of Toronto

References

• GLP-1 Drugs Linked to Higher Risk of Age-Related Macular Degeneration